Patrick Wood
Stock Analyst at Morgan Stanley
(2.97)
# 1,562
Out of 5,053 analysts
108
Total ratings
45%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $17 | $15.81 | +7.53% | 5 | Nov 10, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $72.85 | +9.81% | 8 | Oct 30, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $125 → $130 | $100.60 | +29.22% | 7 | Oct 23, 2025 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $70.52 | +7.77% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $74.19 | +7.83% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $180.06 | +9.41% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $263.82 | +11.82% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $124.60 | -1.28% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $16.00 | -18.75% | 8 | Aug 1, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $31.16 | +118.23% | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $83.50 | -2.99% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $82 → $89 | $55.24 | +61.12% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $17.78 | +51.90% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $10.01 | -10.09% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $71.65 | +43.75% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $86.61 | -16.87% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $106.81 | +61.97% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $320.47 | -1.08% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $4.72 | +111.86% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $26.84 | +37.85% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $120.39 | - | 5 | Dec 11, 2017 |
Tandem Diabetes Care
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $13 → $17
Current: $15.81
Upside: +7.53%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $72.85
Upside: +9.81%
Boston Scientific
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $100.60
Upside: +29.22%
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $70.52
Upside: +7.77%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $74.19
Upside: +7.83%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $180.06
Upside: +9.41%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $263.82
Upside: +11.82%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $124.60
Upside: -1.28%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $16.00
Upside: -18.75%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $31.16
Upside: +118.23%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $83.50
Upside: -2.99%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $55.24
Upside: +61.12%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $17.78
Upside: +51.90%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $10.01
Upside: -10.09%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $71.65
Upside: +43.75%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $86.61
Upside: -16.87%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $106.81
Upside: +61.97%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $320.47
Upside: -1.08%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $4.72
Upside: +111.86%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $26.84
Upside: +37.85%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $120.39
Upside: -